• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

N-Despropyl-N-ethyl Macitentan (CAS No. 441796-13-0): A Comprehensive Overview

N-Despropyl-N-ethyl Macitentan (CAS No. 441796-13-0) is a specialized metabolite of Macitentan, a well-known endothelin receptor antagonist. This compound has garnered significant attention in pharmaceutical research due to its potential therapeutic applications. As a derivative of Macitentan, it plays a crucial role in understanding the pharmacokinetics and metabolism of the parent drug. Researchers and pharmaceutical companies are increasingly interested in N-Despropyl-N-ethyl Macitentan for its unique properties and implications in drug development.

The chemical structure of N-Despropyl-N-ethyl Macitentan features modifications that differentiate it from Macitentan. These alterations influence its binding affinity and metabolic stability, making it a subject of interest for scientists exploring endothelin receptor antagonists. The compound's CAS number, 441796-13-0, serves as a unique identifier in chemical databases, ensuring accurate referencing in academic and industrial research.

One of the most frequently searched questions related to N-Despropyl-N-ethyl Macitentan is its role in pulmonary arterial hypertension (PAH) treatment. Given the rising prevalence of PAH globally, understanding the metabolites of Macitentan, such as N-Despropyl-N-ethyl Macitentan, is critical for optimizing therapeutic regimens. Researchers are investigating whether this metabolite contributes to the efficacy or side effects of Macitentan, a topic that has sparked numerous discussions in medical forums and publications.

Another hot topic in the context of N-Despropyl-N-ethyl Macitentan is its pharmacokinetic profile. Scientists are keen to determine how this metabolite is absorbed, distributed, metabolized, and excreted in the body. Such studies are essential for drug safety assessments and for designing personalized medicine approaches. The compound's stability under various physiological conditions is also a key area of investigation, particularly in the development of novel drug formulations.

In addition to its pharmacological significance, N-Despropyl-N-ethyl Macitentan is also relevant in the field of analytical chemistry. Advanced techniques like liquid chromatography-mass spectrometry (LC-MS) are employed to detect and quantify this metabolite in biological samples. These methods are crucial for clinical trials and therapeutic drug monitoring, ensuring that patients receive optimal doses of Macitentan and its metabolites.

The synthesis and characterization of N-Despropyl-N-ethyl Macitentan are also areas of active research. Chemists are exploring efficient synthetic routes to produce this compound in high purity for use in reference standards and bioanalytical studies. The demand for high-quality N-Despropyl-N-ethyl Macitentan standards is growing, particularly in pharmaceutical quality control laboratories.

From a regulatory perspective, N-Despropyl-N-ethyl Macitentan is subject to stringent guidelines to ensure its safe use in research and development. Regulatory agencies require comprehensive data on its toxicological profile and environmental impact before it can be widely utilized. Compliance with these regulations is paramount for pharmaceutical companies aiming to incorporate this metabolite into their drug development pipelines.

Looking ahead, the future of N-Despropyl-N-ethyl Macitentan research appears promising. With advancements in biotechnology and drug discovery, this compound could unlock new therapeutic possibilities. Its role in precision medicine and targeted therapies is particularly exciting, offering hope for patients with conditions like PAH and other cardiovascular diseases.

In summary, N-Despropyl-N-ethyl Macitentan (CAS No. 441796-13-0) is a compound of significant scientific and medical interest. Its unique properties, coupled with its relevance to Macitentan metabolism, make it a valuable subject for ongoing and future research. As the pharmaceutical industry continues to evolve, N-Despropyl-N-ethyl Macitentan will undoubtedly remain a key player in the quest for innovative and effective treatments.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)